Pharma News

The remarkable ability of a small Australian sea snail to produce a colourful purple compound to protect its eggs is proving even more remarkable for its potential in a new anti-cancer pharmaceutical.

The All of Us Research Program, part of the National Institutes of Health, has awarded a combined $9.1 million in initial funding to two organizations to further the program’s extensive community engagement efforts. HCM Strategists, of Washington, D.C., and the University of Utah, Salt Lake City, will develop innovative approaches to educate communities and support enduring relationships with program participants.

The National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health, has funded three new awards and renewed the awards of eight institutions previously funded under the Research Centers in Minority Institutions (RCMI) Specialized Centers program. The RCMI develops and strengthens the research infrastructure necessary to conduct state-of-the-art biomedical research and foster the next generation of researchers from underrepresented populations. The centers will share approximately $187 million over their five-year project periods, subject to available funds.

An innovative graphene-based film helps shield people from disease-carrying mosquitos, according to a new study funded by the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health. The research, conducted by the Brown University Superfund Research Center, Providence, Rhode Island, is published in the Proceedings of the National Academy of Sciences.

Strides Pharma Science Limited (Strides) announced that its step down subsidiary Strides Pharma Inc.(SPI) has acquired a USFDA(FDA) approved manufacturing facility in Florida, US from Micelle BioPharma, Inc.

The All of Us Research Program(link is external), part of the National Institutes of Health, has awarded $4.6 million in initial funding to Color(link is external), a health technology company in Burlingame, California, to establish the program’s nationwide genetic counseling resource. With the goal of speeding up health research breakthroughs, All of Us plans to sequence the genomes of 1 million participants from diverse communities across the United States. Through this funding, Color’s network of genetic counselors will help participants understand what the genomic testing results mean for their health and their families.

Researchers believe that stuttering — a potentially lifelong and debilitating speech disorder — stems from problems with the circuits in the brain that control speech, but precisely how and where these problems occur is unknown. Using a mouse model of stuttering, scientists report that a loss of cells in the brain called astrocytes are associated with stuttering. The mice had been engineered with a human gene mutation previously linked to stuttering. The study(link is external), which appeared online in the Proceedings of the National Academy of Sciences, offers insights into the neurological deficits associated with stuttering.

U.S. Food and Drug Administration posted a warning letter to Ningbo Huize Commodity Co., an over-the-counter (OTC) drug manufacturer, for significant current good manufacturing practice (CGMP) violations, including data integrity issues.

EMA and the US Food and Drug Administration (FDA) are aligned in more than 90% of marketing authorisation decisions for new medicines.